Mika Scheinin spends much of his time researching Internal medicine, Endocrinology, Pharmacology, Anesthesia and Dexmedetomidine. Mika Scheinin has included themes like Genotype and Cardiology in his Internal medicine study. His study in Endocrinology is interdisciplinary in nature, drawing from both Agonist, Homovanillic acid and Antagonist.
His Pharmacology study incorporates themes from Receptor, Adrenergic receptor, Serotonin, Atipamezole and Dopamine. His research in Anesthesia intersects with topics in Surgery and Blood pressure. The concepts of his Dexmedetomidine study are interwoven with issues in Premedication, Pharmacokinetics and Medetomidine.
Mika Scheinin focuses on Internal medicine, Endocrinology, Pharmacology, Anesthesia and Dexmedetomidine. His work on Cardiology expands to the thematically related Internal medicine. His Endocrinology research incorporates themes from Agonist, Homovanillic acid and Monoamine neurotransmitter.
His Pharmacology research incorporates elements of Atipamezole, Receptor, Antagonist and Clonidine. Mika Scheinin combines subjects such as Molecular biology and Stereochemistry with his study of Receptor. Mika Scheinin has researched Anesthesia in several fields, including Medetomidine, Heart rate and Crossover study.
His main research concerns Anesthesia, Pharmacology, Internal medicine, Dexmedetomidine and Crossover study. His Anesthesia research includes elements of Pharmacokinetics and Medetomidine, Heart rate. His work carried out in the field of Pharmacology brings together such families of science as Agonist, Receptor, Antagonist, Ligand and In vivo.
Mika Scheinin has included themes like Gastroenterology, Endocrinology and Placebo-controlled study in his Internal medicine study. As a part of the same scientific family, he mostly works in the field of Endocrinology, focusing on Antagonism and, on occasion, Blockade. His work deals with themes such as Premedication, Sedative, Sympatholytic and Propofol, which intersect with Dexmedetomidine.
Mika Scheinin mainly focuses on Pharmacology, Anesthesia, Crossover study, In vivo and Striatum. The study incorporates disciplines such as Receptor, Antagonist, Ligand and Apoptosis in addition to Pharmacology. His study on Crossover study also encompasses disciplines like
His In vivo study incorporates themes from Cerebellum, Positron emission tomography, In vitro and Pathology. His Striatum study combines topics in areas such as Neurotransmitter and Human brain. Endocrinology and Internal medicine are inextricably linked to his Neurotransmitter research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Different metabolic responses of human brown adipose tissue to activation by cold and insulin.
Janne Orava;Pirjo Nuutila;Martin E. Lidell;Vesa Oikonen.
Cell Metabolism (2011)
Gene targeting — homing in on α2-adrenoceptor-subtype function
Ewen MacDonald;Brian K. Kobilka;Mika Scheinin.
Trends in Pharmacological Sciences (1997)
Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep
Huupponen E;Maksimow A;Lapinlampi P;Särkelä M.
Acta Anaesthesiologica Scandinavica (2008)
PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.
N. M. Kemppainen;S. Aalto;I. A. Wilson;K. Någren.
Neurology (2007)
Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine.
Pekka Talke;Charles A. Richardson;Mika Scheinin;Dennis M. Fisher.
Anesthesia & Analgesia (1997)
Dexmedetomidine, an α2-adrenoceptor Agonist, Reduces Anesthetic Requirements for Patients Undergoing Minor Gynecologic Surgery
Riku Aantaa;Jussi Kanto;Mika Scheinin;Antero Kallio.
Anesthesiology (1990)
Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy
Helena Tuunanen;Erik Engblom;Alexandru Naum;Kjell Någren.
Circulation (2008)
Effects of dexmedetomidine, a selective α2‐adrenoceptor agonist, on hemodynamic control mechanisms
Antero Kallio;Antero Kallio;Mika Scheinin;Mika Scheinin;Markku Koulu;Markku Koulu;Riitta Ponkilainen;Riitta Ponkilainen.
Clinical Pharmacology & Therapeutics (1989)
DEXMEDETOMIDINE ATTENUATES SYMPATHOADRENAL RESPONSES TO TRACHEAL INTUBATION AND REDUCES THE NEED FOR THIOPENTONE AND PEROPERATIVE FENTANYL
B. Scheinin;L. Lindgren;T. Randell;H. Scheinin.
BJA: British Journal of Anaesthesia (1992)
Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease
N. M. Kemppainen;S. Aalto;I. A. Wilson;K. Någren.
Neurology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Turku University Hospital
University of Helsinki
Stanford University
University of Helsinki
Vanderbilt University Medical Center
University of Helsinki
Turku University Hospital
Odense University Hospital
Stockholm County Council
Vanderbilt University Medical Center
Chapman University
University of Sydney
McGill University
Max Planck Society
University of Massachusetts Medical School
Louisiana State University
Research Institute of Molecular Pathology
University of Arizona
University of New South Wales
Lund University
Konkuk University
Florida State University
Kyoto Prefectural University of Medicine
The University of Texas MD Anderson Cancer Center
Northwestern University
University of California, San Francisco